FindTrial
Sign In

To study the outcomes of treatments prescribed by pulmonologists for post TB COPD patients

Treatment outcome among Post TB COPD labelled patients: A prospective cohort study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062197
Enrollment
200
Registered
2024-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: NIL: NIL

Sponsors

Cipla Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and female participants =18 years of age 2.Diagnosed cases of Post TB COPD (cured from TB) 3.Spirometry FEV1/FVC 4.Symptomatic – Any respiratory symptoms

Exclusion criteria

Exclusion criteria: 1. Participants below the age of 18 years 2. Participants unable to perform spirometry or/and lung oscillometry. 3. Participants not willing to provide consent to participate. 4. Relapse cases of TB 5. TB patients who are on Koch’s treatment 6. Cases of Asthma or all those who have not developed COPD post TB recovery

Design outcomes

Primary

MeasureTime frame
1.Change in symptoms. 2.Quality of life 3.Exacerbations-need for hospital visit or hospitalizations 4.Spirometry and oscillometry parametersTimepoint: Baseline, 1 month and 3 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Sundeep Salvi

Pulmocare Research and Education Foundation

sundeepsalvi@gmail.com9921211000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026